Tag: Karuna Therapeutics Inc
Big pharma Merck, Bristol Myers, J&J prepare to lose revenue
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSEBig pharmaceutical companies such as Bristol Myers Squibb, M [...]
Bristol Myers Squibb to buy Karuna Therapeutics
Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share.Kar [...]
Uranium Energy is too hot for me right now
PepsiCo: "PepsiCo is in the [CNBC Investing Club bullpen]. We think a lot of it. I just wish the stock would come down. It doesn't seem to want to com [...]
Cramer’s lightning spherical: Teladoc is price shopping for
Teladoc Health: "I believe Teladoc is a part of the best way to have the ability to maintain prices down in well being care and we have been behind [...]
IPOs general beat the market this yr regardless of some ‘mega busts’
Ethan Brown, founder and chief govt officer of Past Meat Inc., middle, rings the opening bell through the firm's preliminary public providing (IPO) [...]
Medical wonders, looser FDA made biotech a high funding since 2010
Alex Raths | Getty PhotographsBiotechnology was one of many decade's finest investments as a dizzying tempo of medical innovation fueled the invent [...]
Karuna ‘cautiously optimistic’ on new schizophrenia drug in section Three trial
Karuna Therapeutics CEO Dr. Steve Paul advised CNBC on Friday that the biotech agency is hopeful its new remedy for schizophrenia will show efficie [...]
7 / 7 POSTS